Composite Immune Modulator and Adaptogen Formulation for Inflammation Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapies fail to effectively address the increase in inflammation and decrease in detoxifying defenses associated with physiological stress and aging, leading to adverse effects such as increased TNF-α expression, protein carbonyls, central fat mass, and body mass.
Innovation Solution
A therapeutic composition combining immune modulators like transfer factor and adaptogenic nutrients, including Rhaponticum carthamoides, Schisandra chinensis, ALCAR, Camellia sinensis, Withania somnifera, Curcuma longa, Polygonum cuspidatum, Piper nigrum, and Piperine, which are formulated to reduce inflammatory responses and enhance detoxification defenses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If current therapies are used, then treatment is provided, but they fail to effectively reduce inflammation and increase TNF-α expression
Solution Approach 1:
The patent combines multiple immune modulators (transfer factor, low molecular weight fraction immune modulator) with multiple adaptogenic nutrients (Rhaponticum carthamoides, Schisandra chinensis, Camellia sinensis, Withania somnifera, Curcuma longa, Polygonum cuspidatum, Piper nigrum) into a composite therapeutic composition. This composite approach addresses inflammation more effectively than current single-agent therapies by synergistically targeting multiple inflammatory pathways and enhancing detoxifying defenses simultaneously.
2Weight of stationary object
If current therapies are used, then treatment is provided, but they fail to effectively decrease central fat mass and body mass
Solution Approach 1:
The therapeutic composition integrates immune modulators with specific adaptogenic nutrients known to influence metabolism and fat distribution. The combination includes compounds that target adipose tissue metabolism, cortisol regulation, and inflammatory pathways associated with central obesity, providing a multi-mechanism approach to decreasing central fat mass and body mass that overcomes the limitations of current single-therapy approaches.
3Object-affected harmful factors
If current therapies are used, then treatment is provided, but they fail to effectively enhance detoxifying defenses
Solution Approach 1:
The patent incorporates multiple adaptogenic nutrients with documented detoxification properties, including Rhaponticum carthamoides (supports liver detoxification), Schisandra chinensis (enhances antioxidant defenses), and Curcuma longa (supports phase II detoxification pathways). This composite formulation works synergistically to enhance the body's intrinsic detoxifying defenses more effectively than current therapies.
Data Source
AI summary
Therapeutic compositions for addressing physiological stresses and aging include an immune modulator and one or more adaptogenic nutrients. Some non-limiting examples of immune modulators include as transfer factor, low molecular weight fraction immune modulators and/or other low molecular weight fractions of colostrum, egg or any other source of transfer factor or low molecular weight fraction immune modulators. Methods for administering immune modulators and adaptogenic nutrients to a subject to address the effects of physiological stresses and aging in the body of the subject, such as inflammatory responses, are also disclosed.